Experiment 909596
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | ANON:. (1990). TAXOL.. 15(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | 17 PATIENTS WITH REFRACTORY LEUKEMIA WERE USED IN A PHASE I TRIAL. SIDE EFFECTS INCLUDED SEVERE MUCOSITIS, PERIPHERAL NEUROPATHY, ALOPECIA, MYALGIAS/ARTHRALGIAS, NAUSEA, VOMITING, DIARRHEA AND ACUTE PULMONARY REACTION TO THE VECHICLE CREMOPHOR. MAXIMUM TOLERATED DOSE RECOMMENDED FOR PHASE II TRIAL WAS 390 AND 315 MG/SQ.M. |
| Dose amount | VAR |
| Number | 8 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |